Boston Scientific
Cardiovascular Devices · Neurotech & Neuromodulation

Boston Scientific revenue, results and funding

Boston Scientific filed revenue of $20.1B for 2025.

Data updated Nov 20, 2026 · Back to the company report
$20.1BRevenue, 2025
$2.9BNet income, 2025
BSXNew York Stock Exchange
$7MPublic grants

Results by year

YearRevenueNet incomeTotal assetsLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_DIVIDENDSLANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASHLANG_CR_S_M_DEBTLANG_CR_S_M_ACQUISITIONS
2025$20.1B$2.9B$43.7B$561M$493M––$876M$299M$2.1B$3.6B$2B–$1.6B
2024$16.7B$1.8B$39.4B$656M$436M$0–$790M$266M$1.6B$2.6B$414M–$4.6B
2023$14.2B$1.6B$35.1B$512M$393M$28M–$711M$233M$1.4B$2.3B$865M–$1.8B
2022$12.7B$698M$32.5B$662M$443M$55M$0$588M$220M$1.3B$1.6B$928M–$1.5B
2021$11.9B$1B$32.2B$302M$36M$55M$0$554M$194M$1.2B$1.2B$1.9B–$2.3B
2020$9.9B−$82M$30.8B$207M$2M$28M$535M$376M$170M$1.1B−$80M$1.7B–$3M
2019$10.7B$4.7B$30.6B$242M−$4B$0$0$461M$157M$1.2B$1.5B$217M–$4.4B
2018$9.8B$1.7B$21B$1B−$249M$0$0$316M$140M$1.1B$1.5B$146M–$1.4B
2017$9B$104M$19B$42M$828M––$319M$127M$997M$1.3B$188M$3.8B$560M
2016$9.1B$347M$18.1B$94M−$170M–$0$376M$116M$920M$447M$196M$5.4B$408M
2015$8.1B−$239M$18.1B$80M−$411M–$0$247M$107M$876M−$283M$319M$5.7B$1.7B
2014$7.5B−$119M$17B$74M−$390M–$125M$259M$103M$817M−$301M$587M$4.2B$486M
2013$7.1B−$121M$16.6B$67M−$102M–$500M$245M$105M$861M$120M$217M$4.2B$274M
2012$7.2B−$4.1B$17.2B$97M−$39M–$600M$226M$108M$886M−$3.9B$207M$4.2B$366M
2011$7.6B$441M$21.3B$138M$201M–$492M$304M$128M$895M$904M$267M$4.2B$370M
Sources: SEC

Rounds and grants

YearRoundAmount
2023Grant$179k
2023Grant$67k
2022Grant$949k
2021Grant$1.9M
2020Grant$509k
2020Grant$270k
2020Grant$64k
2019Grant$395k
2018Grant$128k
2017Grant$870k
2017Grant$330k
2016Grant$550k
2015Grant$772k
Sources: funding announcements, SEC filings, grant registers

How to cite

Boston Scientific, Financials. Alion, Nov 20, 2026. https://alion.io/company/bostonscientific-com/financials

.json · .md · CC BY-SA 4.0